Tech Company Financing Transactions

Aro Biotherapeutics Funding Round

Cowen Healthcare Investments, BVF Partners and Healthcap Venture Capital participated in a $41.5 million Series B venture round for Aro Biotherapeutics. This venture round was announced by the company on 11/28/2023.

Transaction Overview

Company Name
Aro Biotherapeutics
Announced On
11/28/2023
Transaction Type
Venture Equity
Amount
$41,500,000
Round
Series B
Investors

Cowen Healthcare Investments (Lead Investor)

BVF Partners

Healthcap Venture Capital

Johnson & Johnson Innovation

Northpond Ventures (Shaan Gandhi)

Proceeds Purpose
Aro will use the funds to advance development of its lead program, ABX1100, a novel potential treatment for patients with Pompe Disease. Aro recently announced the start of a first-in-human with ABX1100, and the Company anticipates that initial data from this study will be presented in 2024. In addition, the Series B funding will support new Centyrin-siRNA conjugate programs focused on the discovery of new therapies for autoimmune disorders.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3675 Market St. 200
Philadelphia, PA 19104
USA
Phone
Undisclosed
Website
www.arobiotx.com
Email Address
[email protected]
Overview
Aro Biotherapeutics is focused on the development of a new protein drug platform called Centyrins, designed to achieve better efficacy and safety profiles for patients with cancer and other serious diseases.
Profile
Aro Biotherapeutics LinkedIn Company Profile
Social Media
Aro Biotherapeutics Company Twitter Account
Company News
Aro Biotherapeutics News
Facebook
Aro Biotherapeutics on Facebook
YouTube
Aro Biotherapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Susan Dillon
  Susan Dillon LinkedIn Profile  Susan Dillon Twitter Account  Susan Dillon News  Susan Dillon on Facebook
Chief Scientific Officer
Karyn O'Neil
  Karyn O'Neil LinkedIn Profile  Karyn O'Neil Twitter Account  Karyn O'Neil News  Karyn O'Neil on Facebook
VP - Administration
Mark Laurenzi
  Mark Laurenzi LinkedIn Profile  Mark Laurenzi Twitter Account  Mark Laurenzi News  Mark Laurenzi on Facebook
VP - Bus. Development
Scott Greenberg
  Scott Greenberg LinkedIn Profile  Scott Greenberg Twitter Account  Scott Greenberg News  Scott Greenberg on Facebook
VP - R & D
Steven Nadler
  Steven Nadler LinkedIn Profile  Steven Nadler Twitter Account  Steven Nadler News  Steven Nadler on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/28/2023: CoordinateHQ venture capital transaction
Next: 11/28/2023: LegalFly venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.